Heron Therapeutics (HRTX) Debt Ratio (2016 - 2026)

Heron Therapeutics has reported Debt Ratio for 6 years, with the latest figure at 0.44 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio rose 311.31% year-over-year to 0.44; the trailing twelve-month figure through Mar 2026 stood at 0.44 (up 311.31% YoY), and the FY2025 full-year result was 0.42, up 292.85% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.44, up from 0.42 in the prior quarter.
• The five-year high for Debt Ratio was 0.44 in Q1 2026, with the low at 0.1 in Q3 2023.
• Historically, Debt Ratio has averaged 0.21 across 4 years, with a median of 0.11 in 2024.
• Annual changes were most pronounced in 2025 — Debt Ratio dropped 4.68% — and 2026, when it soared 311.31%.
• Heron Therapeutics' Debt Ratio stood at 0.11 in 2023, then declined by 1.56% to 0.11 in 2024, then soared by 292.85% to 0.42 in 2025, then advanced by 4.32% to 0.44 in 2026.
• The last three Debt Ratio figures came in at 0.44 (Q1 2026), 0.42 (Q4 2025), and 0.43 (Q3 2025), per Business Quant data.